SCIEX

Brea, CA, United States
Brea, CA, United States
SEARCH FILTERS
Time filter
Source Type

FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies, announced today that EPL Bio Analytical Services, (EPL BAS), an industry leading agriculture-focused analytical contract laboratory, has selected the SCIEX QTRAP® 6500+ with SelexION®+, enabling their researchers to provide analytical solutions to customers with projects involving difficult matrices that the lab could not previously consider accepting. EPL’s analytical laboratory provides customized analytical laboratory testing services to the agricultural crop protection, agricultural chemical, agricultural biotechnology, organic, biocontrol, nutritional, food ingredient, and feed industries and they partner with customers from around the world to provide safe and reliable agricultural products to local and global consumers. EPL’s installation of the SCIEX QTRAP 6500+ LC-MS/MS system with multi-component IonDrive™ Technology and a newly designed IonDrive High Energy Detector+, offers them the high sensitivity, reliability and confidence they require to produce data as objective evidence for the efficacy and safety of a wide range agricultural product, including organic products, synthetic chemistry and plant incorporated protectants. The QTRAP 6500+ system delivers enhanced selectivity, without compromising MRM sensitivity, for more flexibility in dealing with complex interferences. The exclusive QTRAP scan function of MS3 (MS/MS/MS), adds an additional level of mass filtering, while the SelexION+ ion mobility provides an orthogonal separation prior to mass separation and offers the lab yet another tool for eliminating isobaric background interferences in complex assays, making quantitation in complex samples easier and less time consuming. The unique scan functions offered by the SCIEX QTRAP system, including enhanced mass scans (EMS), enhanced resolution scans (ER), and enhanced product ion scans (EPI), deliver maximum flexibility and workflow options enabling researchers to embrace new discoveries and more accurate identification that extend beyond quantitation. “The 6500+ with SelexION allows EPL Bio Analytical Services to have unique product offering and provides a significant competitive advantage that enables their researchers to solve problems other labs cannot,” said Paul Winkler, Food and Beverage Marking Development Manager, Americas at SCIEX. “The acquisition of the QTRAP 6500+ provides EPL Bio Analytical Services with an instrument that has better low mass negative ion performance than their competitors’ laboratories, and with the addition of SelexION, EPL Bio Analytical Services further extends their ability to perform analyses in complex matrices such as environmental and agricultural samples.” “At EPL, the management and staff place a high value on being the industry leader,” said Fred Claussen, VP of Method Development EPL Bio Analytical Services. “When we find a technology that will provide better data to our customers, we go get it. In the competitive world of contract laboratories, having the best technology, along with the best technical staff allows us to more effectively compete for new business and uphold our strong brand on a global level. We believe that the acquisition of these SCIEX solutions gives our laboratory this important competitive edge.” Learn more about SCIEX QTRAP and SelexION Technology SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com. For Research Use Only. Not for use in diagnostic procedures. RUO-MKT-12-6044-A ©2017 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license. EPL Bio Analytical Services (EPL BAS) is an award-winning, Good Laboratory Practice compliant (GLP), ISO 17025-accredited analytical contract lab. Our vision is to be the “most trusted analytical laboratory in the Ag Industry.” EPL BAS serves the global agricultural industry by analyzing feed and food ingredients, organic products, genetically enhanced crops, bio-pesticides, plants, algae, plant protection agents and crop chemicals. With the goal of providing safe, healthy, and abundant food while protecting and improving the environment, EPL BAS uses advanced innovative technology in the areas of nutritional chemistry, agricultural chemistry, including residue and product chemistry, and molecular biology to provide excellent, timely support for the feed, food, fiber and fuel industries. We don’t have an Ag Division…because we are Ag! Visit us at www.eplbas.com, Facebook, LinkedIn and Twitter.


FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies, today announced that it has launched its game-changing SWATH® data independent acquisition (DIA) technology for analytical scientists working across all application areas. SWATH Acquisition is ground-breaking in allowing the simultaneous and comprehensive identification and quantification of virtually every detectable compound in a sample, from a single analysis (MS/MSALL). SWATH Acquisition has unique capabilities for quantitative accuracy, offering exceptionally high reproducibility across multiple samples with wide dynamic range. Importantly, the technology enables the creation of a permanent digital record of quantitative MS/MS data for the entire sample. Following the successful implementation of SWATH for proteomics research, this technology is widely used today in the industrialization of proteomics research and can now bring significant advantages for analytical scientists in other fields, including forensics, food testing, environmental analysis, and biologics. The transition from traditional proteomics workflows to the SCIEX patented SWATH® Acquisition has transformed proteomics experiments, allowing all data to be robustly captured across very large sample cohorts to enable industrialized proteomics and precision medicine approaches. The ability of the SCIEX TripleTOF® system technology to acquire high resolution MS/MS spectra at high acquisition rates has made it the only mass spectrometer on which SWATH Acquisition can be routinely performed. Now with the new X500 series mass spectrometers, with the similar acquisition rates, on a routine use system SWATH Acquisition is now poised to revolutionize other fields. For example, food-testing laboratories survey ingredients and food products for quality and safety. Pesticide residues in certain foods such as baby food are required to be as low as under 10 µg/kg, and foods such as fruits or vegetables often exhibit a high number of active components and can be difficult to analyze. When using traditional LC-MS/MS approaches to analyze complex matrices such as foods, there is a risk of missing the identification of an important low level residue. SWATH Acquisition eradicates this issue, allowing scientists to completely survey samples for every detectable chemical contaminant present while also ensuring rapid, reliable detection of low abundance compounds that are usually masked by dominant compounds in a sample. Laboratories investigating water quality carry out rigorous treatment and testing procedures to identify a variety of chemical hazards. The difficulty with water analysis is that substances can be present at exceptionally low concentrations, in the range of low nanograms per liter, and a single sample may contain hundreds of contaminants. SWATH technology collects ultra-high quality MS and MS/MS on all detectable peaks to provide rapid and reliable identification and quantification of compounds in samples. Characterization and quantification of host cell proteins is an important stage in the development of biotherapeutics. Even with rigorous purification processes, small amounts of host cell proteins may be present in the final product. Traditional analysis methods including ELISA are not comprehensive enough to detect previously unknown HCP contaminants, and standard information dependent LC-MS strategies are not sensitive enough to detect low-level peptides in a reproducible manner. The unbiased SWATH Acquisition approach in contrast enables the detection of peptides down to very low levels in the sample, allowing researchers to generate reproducible data which is crucial for drug development studies. Forensic testing involves routine screening and quantification of drugs and medications in numerous biological matrices, such as blood. This testing requires robust hardware, reproducible results and highly sensitive analysis. SWATH technology collects comprehensive MS data and MS/MS data from a single sample injection, which results in a digital archive of the forensic sample. This allows re-interrogation of the sample without physical re-analysis, removing the need for expensive and inconvenient sample storage, and saving time. This unbiased solution also provides high quality results that will stand up in court. “The most important aspect of the X500R QTOF System is the ability to work with SWATH Acquisition, especially when analyzing food samples with complex matrices,” said Dr. Amadeo R Fernaìndez-Alba, Head of the European Union Reference Laboratory (EURL) for Fruits and Vegetables, and Professor of Analytical Chemistry at the University of Almeria. “It also enables fast quantification, making it ideally suited to high-throughput applications, without compromising on sensitivity.” “As environmental chemists, we are always trying to find new compounds of concern, whether in drinking water, stormwater, or biota,” said Christopher Higgins, Ph.D., Associate Professor, Department of Civil and Environmental Engineering, Colorado School of Mines. “SWATH looks to provide us an opportunity to collect and archive data, thereby allowing us to re-examine old data without reacquisition. This is an important advantage in environmental monitoring where samples are often limited.” “The beauty of SWATH is that it collects data for everything,” said Dr. Thomas Kofoed, Chief Executive Officer, Alphalyse. “It allows us to identify and quantify each host cell protein reliably in drug batches, and provide a service that customers can trust.” “SWATH is our preferred method for broad-based drug screening when using SCIEX QTOF systems, because SWATH enables the generation of accurate library MS/MS spectral matching results reducing the possibility of false negative identifications,” said Dr. Barry Logan, Executive Director, The Center for Forensic Science Research Education. “Essentially, SWATH provides reliable results for analytes that are toxicologically relevant to forensic investigations because of the complete MS/MS coverage that it provides.” SCIEX will highlight the latest additions to its growing line of mass spectrometry-based solutions at ASMS 2017, June 4-8 in Indianapolis. SCIEX will present customer driven innovations and advancements for all markets, at booth #500 and in their hospitality suite at the JW Marriott – White River Ballroom ABE. Learn more about why only SCIEX can do SWATH SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com. For Research Use Only. Not for use in diagnostic procedures. RUO-MKT-12-5418-A © 2017 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.


SHANGHAI--(BUSINESS WIRE)--SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today that the AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS system has been approved by the China Food and Drug Administration (CFDA) and meets the market access requirements for medical device products. With this accreditation, SCIEX aims to help propel China’s clinical laboratory programs to a new level by meeting the challenges of clinical diagnostic labs to deliver highly accurate and reliable test results. The AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS system consists of a triple quadrupole mass spectrometer (TRIPLE QUADTM 4500MD), a high-performance liquid chromatography system (JasperTM), and software including Analyst®MD, Cliquid®MD and MultiQuantTMMD and it is intended to use with various reagents to analyze compounds in human specimens. The compounds include diagnostic indicators (endogenous substances: amino acids, vitamins, hormones) and therapeutic monitoring compounds (exogenous substances: therapeutic / toxic drugs). The AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS system delivers excellent detection levels for the analytes commonly requested in clinical in vitro diagnostic applications. Designed to maximize uptime in clinical laboratories and support continuous high-throughput operations, the AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS system features the industry leading SCIEX Turbo V™ ion source and Curtain Gas™ interface for outstanding reliability, sensitivity and reproducibility in routine clinical testing and ensures day-to-day, month-to-month, or week-to-week measurement consistency. The AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS system provides scientists with the ability to perform multiple assays, and quantitate multiple compounds in a single run with a suitable reagent, resulting to fewer tests, significant time and cost savings in clinical laboratories. “We are very pleased to share this news to with our customers and with the industry. We know that the routine diagnostic testing lab requires accurate trace level quantitation of multiple compounds in human specimens,” said Shao Hong, SCIEX China GM. “The AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS system is a truly reliable platform, which can help meet clinical lab objectives, by saving time, cutting costs, and supporting physicians with greater confidence and reliable results. We believe that AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS system will lead us to a new era in clinical in vitro diagnostic field.“ Learn more about the SCIEX Triple Quad 4500MD system. SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com. For in vitro diagnostic use. Rx Only. IVD-MKT-12-6126 ©2017 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.


News Article | June 1, 2017
Site: www.businesswire.com

FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies, today announced that at ASMS 2017, it will highlight the cutting-edge innovations developed to power their most advanced LC-MS instrumentation and workflows, and is now enabling streamlined workflows making mass spec more accessible to routine users and non-mass spec experts. SCIEX is committed to developing optimized solutions in support of the whole Precision Medicine continuum, from biomarker research to clinical implementation. As such, SCIEX will share how several customer partnerships are key to advancing biomarker discoveries via their industrialized omics pipelines. In addition, they will highlight the first and only FDA-cleared (via the de novo pathway) LC-MS based Vitamin D assay kit, the Vitamin D 200M Assay, exclusively for the SCIEX Topaz™ System. The Topaz System is a fully integrated LC-MS platform driven by ClearCore™ MD, the new and intuitive software designed specifically for use in clinical labs. An array of scientific presentations and posters will be featured at the ASMS 2017 Annual Users Meeting and Breakfast Seminars, at the Indianapolis Marriott Downtown, 350 West Maryland St, Indianapolis, IN. Among the solutions being featured from the SCIEX comprehensive portfolio are: SWATH® Acquisition: The Evolution of Data Independent Acquisition – Since its commercialization 5 years ago, SWATH Acquisition has continued to advance and evolve. Workflow improvements, including the ability to optimize acquisition with variable sized Q1 windows and microflow for sample throughput have delivered significant increases in the number of proteins and peptides quantified, as many as 150 proteomes per week. Building off the successful implementation of SWATH Acquisition across academic research applications, the technology is now bringing significant advantages in other applications, including metabolomics, forensics, food testing, environmental analysis, and biologics characterization. Biotransformation solutions, two streamlined solutions targeted to customer needs New Biotransformation Solutions for Routine and Comprehensive Metabolism and Biologic Catabolism Studies – The latest additions to its growing line of solutions for pharmaceutical drug discovery and development. The Routine Biotransform Solution and the Advanced Biotransformation Solution are powered by the newest SCIEX MetabolitePilot™ Software 2.0, delivers an easy to use interface that places processing, interpretation and reporting all in one place. Among the presentations and discussions involving SCIEX innovations are: “SCIEX is developing application software for our instruments that doesn’t require analysts to be mass spectrometry experts, while still providing laboratories with the high performance they need for advanced workflows,” said Jean-Paul Mangeolle, President of SCIEX. “The solutions we are presenting at ASMS this year support the workflow improvements that enable our customers to see the future differently by implementing the quality of advanced workflows with the ease of routine.” Throughout the ASMS conference, SCIEX will continue showcasing customer driven innovations and advancements across LC-MS market areas, at booth #500 and in their hospitality suite at the JW Marriott – White River Ballroom ABE. In addition, scientists from SCIEX will present innovative solutions across a range of applications with oral presentations, user meetings, workshops, and posters. Find more information and full agenda for SCIEX at ASMS. To learn more about the SCIEX Vitamin D 200M Assay, available in the United States only from SCIEX: sciex.com/massspecmadesimple Follow SCIEX at ASMS on Twitter and tweet and can utilize hashtag #ASMS2017. SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com. The SCIEX Vitamin D 200M Assay Kit, SCIEX Topaz™ System and ClearCore™ MD software are for in vitro Diagnostic Use. Not available in all countries. All other products discussed in this press release are For Research Use Only. Not for use in diagnostic procedures. © 2017 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.


News Article | July 31, 2017
Site: www.businesswire.com

FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today the launch of the first fully integrated LC-MS system for clinical diagnostics, the SCIEX Topaz™ System. The Topaz System is designed specifically to meet the unique needs of the clinical diagnostic lab, lowering the barriers to adoption of LC-MS and making it accessible to the entire clinical lab staff. The heart of the system lies within the innovative ClearCore™ MD software, a platform which simplifies and streamlines workflows and method development and incorporates features that enhance usability to help new users build proficiency quickly. In addition, the first FDA-cleared (via the de novo pathway) LC-MS based Vitamin D assay kit, the SCIEX Vitamin D 200M Assay, is for use on the SCIEX Topaz System. According to the CDC, LC-MS technology is the gold standard method for testing Vitamin D, as it offers greater specificity and less cross-reactivity over immunoassay methods. The Vitamin D 200M Assay Kit has successfully met the rigorous performance criteria established by the CDC’s Vitamin D Standardization-Certification Program (VDSCP). The assay individually quantitates both Vitamin D2 and D3 while also separating out the D3 epimer, providing the specificity to deliver an accurate measurement of Vitamin D status. The Topaz System offers the ultimate in flexibility with both an open system for lab-developed tests (LDTs) and a closed system for running locked, pre-validated assays. In addition, a turnkey, FDA-cleared Vitamin D solution is available for immediate implementation, so lab staff can be up and running quickly. The Topaz System enables clinical labs to rapidly expand their testing services and bring previously outsourced tests in-house, realizing cost savings along with gold-standard accuracy, in less time, with less complexity - all for the benefit of delivering quality patient care. “SCIEX set out with the goal to making mass spectrometry simple for clinical labs, and the outcome is the first integrated LC-MS-based IVD system that is open by design and closed when you need it,” said Dr. Aaron Hudson, Sr. Director and GM of SCIEX Diagnostics. “The innovative ClearCore MD software simplifies and streamlines workflows and method development, bringing the power of SCIEX LC-MS technology to the hands of the routine user. In conjunction with the first FDA-cleared (via the de novo pathway) Vitamin D LC-MS assay, the Topaz system empowers a lab to do more, save more, and deliver more confident results to support clinicians.” “The Topaz System from SCIEX Diagnostics is the LC-MS that mid-sized clinical labs have been waiting for,” said Dr. Jim Ritchie Professor, Pathology & Laboratory Medicine at the Emory University School of Medicine. “I believe this system is approaching a stage of automation close to that of a chemistry analyzer, in many ways. It was easy to train Med-Techs on and easy to learn to operate, adopt, and sustain in our clinical lab. We believe it’s primed to set the new standard for ease of use.” The introduction of the Topaz System further expands the portfolio of clinical diagnostic solutions offered by the diagnostic companies of Danaher Corporation, which include Beckman Coulter, Cepheid, Leica Biosystems, Radiometer, and SCIEX Diagnostics. The breadth of this portfolio extends from the established to novel diagnostic technologies for clinical and anatomic pathology laboratories and point-of-care testing. With a rich history and a tradition of innovation, the diagnostic companies of Danaher remain committed to developing of new and unique diagnostic approaches for improved, quality patient care, and to helping the healthcare systems build comprehensive and efficient diagnostic services with a high degree of automation, accuracy through standardization, and data connectivity. To learn more about the SCIEX Topaz System: visit sciex.com/MassSpecMadeSimple, the SCIEX booth at AACC July 30 – August 03 in San Diego, U.S., or MSACL September 10 – 14 in Salzburg, Austria. SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciexdiagnostics.com. ©2017 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license. For in vitro diagnostic use. Rx Only. Product(s) not available in all countries. For information on availability, please contact your local representative. SCIEX Vitamin D 200M Assay Kit, available in the United States only. IVD-MKT-12-6116-A


News Article | May 24, 2017
Site: www.businesswire.com

FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today the first and only FDA-cleared (via the de novo pathway) LC-MS based Vitamin D assay kit, the Vitamin D 200M Assay, exclusively for the SCIEX Topaz™ System. The Topaz System is a fully integrated LC-MS platform driven by ClearCore™ MD, the new and intuitive software designed specifically for use in clinical labs. The Office of Inspector General (OIG) recently reported Vitamin D as one of the top five laboratory assays reimbursed by Medicare, accounting for 8.7 million laboratory tests and $337 million in reimbursement dollars. Vitamin D is an important building block for human health, and Vitamin D has been linked in literature to several clinically important diseases. Thus it is necessary to provide physicians with accurate results to allow for confident diagnosis of Vitamin D stores and management of Vitamin D deficiency-related diseases. According to the CDC, LC-MS technology is the gold standard method for testing Vitamin D, offering greater specificity and less cross-reactivity over immunoassay methods. The CDC has established a Vitamin D Standardization-Certification Program (VDSCP) and the SCIEX Topaz Vitamin D 200M Assay Kit has successfully met the rigorous performance criteria. While individually quantitating D2 and D3 isomers, the Topaz System running the Vitamin D 200M Assay Kit, also automatically differentiates between D3 epimers, providing the specificity to deliver highly accurate diagnostic results in a single analysis. The Vitamin D 200M Assay for the Topaz System is intended for in vitro diagnostic use in the quantitative determination of total 25-hydroxyvitamin D (25-OH-D) through the measurement of 25-hydroxyvitamin D3 (25-OH-D3) and 25-hydroxyvitamin D2 (25-OH-D2) in human serum using LC-MS/MS technology by a trained laboratory professional in a clinical laboratory. The Assay is intended for use with the Topaz System. The Vitamin D 200M Assay for the Topaz System is intended to be used in conjunction with other clinical or laboratory data to assist the clinician in making individual patient management decisions in an adult population in the assessment of Vitamin D sufficiency. “Clinical diagnostic labs are challenged every day to deliver highly accurate and reliable test results in order to make critical treatment decisions,” said Dr. Aaron Hudson, Sr. Director and GM of SCIEX Diagnostics. “Through the Topaz System, SCIEX offers a LC-MS-based IVD system that is easy to learn and validate in the clinical lab. It will enable clinical labs to expand their in-house testing services through the SCIEX Vitamin D Assay Kit, as well as add to their own laboratory developed tests (LDTs), thus empowering the lab to do more, save more and deliver more confident results to support clinicians and physicians. The Topaz System from SCIEX Diagnostics is “Mass Spectrometry Made Simple”, and primed to set the new standard for delivering superior patient care.” To learn more about the SCIEX Vitamin D Assay Kit SCIEX Topaz System and the SCIEX Vitamin D 200M Assay Kit, available in the United States only from SCIEX: sciex.com/massspecmadesimple SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciexdiagnostics.com. ©2017 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license. For in vitro diagnostic use. Rx Only. IVD-MKT-12- 5686-A


News Article | May 25, 2017
Site: www.businesswire.com

FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies, has announced that the MSB Strategic Planning Committee has selected Dr. Shigeru Terabe, Professor Emeritus of the University of Hyogo in Kamigori, Hyogo, Japan, as the recipient of the Arnold O. Beckman Medal and Award for Outstanding Scientific Achievements in the Field of Electro-driven Separation Techniques. The Medal Ceremony was presented on Tuesday, March 28th as part of a Special Award Plenary Session at the 33rd International Symposium on Microscale Bioseparations (MSB 2017). The Arnold O. Beckman award is given to an individual for remarkable career achievements, with particular consideration being given to the development of new methods, techniques and high-impact applications in the field of electro-driven separations. The award comprises a Medal, a Diploma and a Monetary Prize. Professor Terabe earned his undergraduate, masters and doctoral degrees from Kyoto University, Japan in 1963, 1965 and 1973, respectively. Professor Terabe began is career at the Shionogi & Company Ltd, where he was a research chemist. Later, he joined Arizona State University, where he was a research associate before returning to Kyoto University, Japan to become an assistant professor. In 1990, he was appointed to the Faculty at Himeji Institute of Technology, Kamigori, Hyogo, Japan and has since been engaged in the practice of analytical chemistry. After retiring, Professor Terabe served as a Research Supervisor of the program “Precursory Research for Embryonic Science and Technology” funded by the Japanese government from 2004–2010. In his role, Professor Terabe assisted 40 top young analytical scientists by funding ca. 5 million USD per year for the project, “Structure Function and Measurement Analysis.” Professor Terabe has been a driving force in understanding the fundamentals of capillary electrophoresis including the introduction of Micellar Electrokinetic Chromatography and a myriad of its applications, as well as the development of sweeping, a “stacking” approach for neutral analytes. His 250 original research publications have been cited more than 15,000 times altogether ranking him in the top 200 among all chemists. Professor Terabe has been awarded the ACS Award in Chromatography in 2004, CASSS Award in 2007, and the Chemical Society of Japan Award in 2008 in recognition of his contributions to analytical chemistry. He served as an Editor of Journal of Chromatography for 15 years and in 2011 he was Chairman of the IUPAC International Congress on Analytical Sciences. “This annual Medal and Award sponsored by SCIEX recognizes the achievements of those that have made a momentous impact on capillary electrophoresis,” said Jeff Chapman, Sr. Director, SCIEX. “Professor Terabe’s invention of micellar electrokinetic chromatography has inspired many scientists, both utilizing and building upon this fundamental methodology.” “I am humbled to be the recipient of the prestigious Arnold O. Beckman award, a notable honor that has recognized distinguished colleagues that have impacted diverse scientific and technical disciplines,” said Dr. Shigeru Terabe, Professor Emeritus of the University of Hyogo in Kamigori, Hyogo, Japan. “Dr. Beckman’s achievements have inspired me and I would like to express my gratitude to MSB for this esteemed award.” Learn more about SCIEX and SCIEX Capillary Electrophoresis Solutions SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com. For Research Use Only. Not for use in diagnostic procedures. RUO-MKT-12-5561-A © 2017 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.


WARRINGTON, England--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies, has announced that two SCIEX researchers have received the Science and Technology Award at the 16th Human Proteome Organization World Congress, HUPO2017, which was recently held in Dublin, Ireland. The award was presented to Stephen Tate and Ron Bonner from SCIEX, for their significant role in the development of SWATH® Acquisition technology commonly referred to as data-independent-acquisition (DIA). “This significant innovation in the proteomics field has had wide acceptance and provides a springboard for proteomics technology to impact the field of translational clinical proteomics,” states the HUPO organization. “The HUPO members applaud the efforts of Dr. Bonner and Dr. Tate for the award in Science and Technology.” During the event, SCIEX featured its advanced quadrupole time-of-flight mass spectrometry proteomics platforms, which enable the SWATH acquisition workflow and allows quantification of thousands of proteins across large sample sets with greater accuracy and reproducibility than ever before. The challenge of unlocking the proteome requires innovative tools and technology to detect and quantify more proteins for deeper insights. The SCIEX TripleTOF® 6600 System in combination with SWATH Acquisition delivers the combination of comprehensive coverage with low coefficients of variation previously achievable only by targeted techniques - providing comprehensive high quality quantitative datasets. SCIEX SWATH Acquisition technology, now celebrating five years since introduced, enables the quantification of thousands of proteins across large sample sets with an unprecedented level of data completeness, quantitative accuracy and reproducibility. SWATH Acquisition allows for comprehensive quantification, which is critical in biomarker or systems biology research. This new technology has transformed proteomics experiments, allowing all data to be captured across very large sample cohorts and now in combination with microflow chromatography, enabling industrialised proteomics. Recently, three primary research articles1 were published, demonstrating the reproducibility of quantitative proteomics data by multiple labs using SWATH Acquisition, discussing how to deal with the false positive inflation issue2, and focusing on post-translational modifications and the inference of peptidoforms algorithm3, respectively. SCIEX presented work on advancing proteomics research at HUPO2017, including a talk by Stephen Tate and Ron Bonner on the development of the SWATH workflow during the congress award session. SCIEX also hosted a seminar entitled “Biomarkers in Ovarian Cancer from SWATH® maps of clinical samples”. The seminar – which was filled to capacity – gave new insights into use of SCIEX solutions for precision medicine research and quantitative proteomics. The invited speaker was Robert Graham Ph.D., Sr Lecturer in Clinical Proteomics, Deputy Director Stoller Biomarker Discovery Centre, University of Manchester. Just prior to the conference, SCIEX hosted a VIP round-table discussion focused on the advancement of precision medicine and the major challenges researchers are faced with. Participating in the in-depth discussion are internationally renowned researchers: “We are pleased to have organised and facilitated so many important discussions with researchers, some from the leading edge of precision medicine to those who are interested in high-performance solutions for quantitative proteome analysis at HUPO2017,” said Mark Cafazzo, Director of Academic and Applied Markets at SCIEX. “We are also happy to celebrate the fifth anniversary of our unique SWATH Acquisition technology and we believe that our cutting-edge technologies and applications will continue to help customers examine the proteome more completely, addressing diverse needs across the research pipeline. We are committed to advancing the leading edge of biomarker research in order to unlock knowledge that will positively impact more people’s lives.” 1. Collins, BC et al., Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry (2017) Nature Communications 8, doi:10.1038/s41467-017-00249-5 2. Rosenberger, G. et al. Statistical control of peptide and protein error rates in large-scale targeted data-independent acquisition analyses. (2017) Nature Methods, doi:10.1038/nmeth.4398. 3. Rosenberger, G. et al. Inference and quantification of peptidoforms in large sample cohorts by SWATH-MS (2017) Nature Biotechnology 35, 781–788. SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com. For Research Use Only. Not for use in diagnostic procedures. RUO-MKT-12-6474-A © 2017 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.


News Article | September 26, 2017
Site: www.businesswire.com

FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies, announced today the program for the 2017 Global CESI-MS Symposium, Oct. 5 and 6 to be held at Barnett Institute, Northeastern University in Boston. This SCIEX event brings together key opinion leaders and industry innovators from around the world to present their latest advancements made through the adoption of CESI-MS technology. This year’s two-day session will be hosted by Dr. Alexander Ivanov from the Barnett Institute and will feature presentations and live Q&A’s in Biopharmaceutical characterization - including MS identification of intact protein charge variants, Proteomics - with a focus on native analysis of intact proteins & Post Translational Modifications (PTM) analysis, Metabolomics - addressing the challenges of charged & polar compounds, and Novel and Advanced Market Applications. Additional session chairs at the 2017 Global CESI-MS Symposium include: Only SCIEX CESI-MS technology allows researchers to reach beyond what can be achieved with traditional technologies to further advance challenging applications in biopharmaceutical, proteomics and metabolomics research, and applied markets testing. This flexible technology platform enables stand-alone CE analysis or pairing with a mass spectrometer (MS) now or in the future, an analysis function sought after by growing contract research organizations (CROs). CESI-MS is used by biopharmaceutical leaders for the characterization of biologics such as monoclonal antibodies (mAbs) and antibody drug conjugates (ADCs) for Intact mAb charge variant analysis, disulfide bond mapping, (glyco) peptide mapping, and for the identification of post-translational modifications. CESI coupled with high-resolution, high-speed MS helps provide complete biotherapeutic sequence coverage, plus identify relevant PTMs (in intact or digested format), even when present at low abundance. “The CESI technology is highly versatile, allowing both multiple modes of separation for proteins, antibodies, glycans, etc., as a standalone CE instrument, and it can directly interface with a mass spectrometer, which can enable deeper insights via further MS/MS analysis of the analytes separated by the CE technology,” said Min Zhao, Ph.D., Director, Analytical Services Biologic Product - CMC Services at Frontage. “When we are establishing the new biologics laboratory, we will depend on the CESI 8000 Plus to provide not only traditional CE based methods, such as CE-SDS, cIEF and glycan analysis, but can also to utilize it as a state of the art CESI-MS/MS tool. In the next few years, we will use the CESI technology to support release and stability testing, and studies for reference standard qualification, forced degradation, comparability, and biosimilarity assessments for our clients’ biologic products, such as cytokines, antibodies, antibody drug conjugates, and protein vaccines, etc., in CMC services.” “The SCIEX TripleTOF™ 6600 MS with the CESI interface enables researchers to acquire all levels of data simultaneously,” said Jeff Chapman, Senior Director of the CE business at SCIEX. “What traditionally has taken three or four experiments for sequence identification, PTMs, and glycan analysis, researchers can now achieve in just a single injection. The 2017 Global CESI-MS Symposium will focus on the additional breakthroughs that CESI is enabling researchers to experience.” To learn from industry leaders and solve separation challenges register here: 2017 Global CESI-MS Symposium, Boston, MA U.S.A. SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com. For Research Use Only. Not for use in diagnostic procedures. RUO-MKT-12-6462-A ©2017 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.


News Article | September 14, 2017
Site: www.prweb.com

Metabolomics focuses on the chemical processes central to cellular metabolism. A robust mass spectrometry solution for screening metabolites is of increased interest allowing for a more integrated and routine analysis. A new QTOF System was developed for routine, robust workflows which require minimal MS expertise. The system integrates all data acquisition, processing and review in a single software. A prostate cancer study was used to determine whether the untargeted metabolomics workflow using the X500R System could find key differences between the samples. In this study, which will be discussed in the webinar, samples from a pilot prostate cancer study were analyzed and a clear difference between healthy and disease urine samples was detected using this untargeted metabolomics approach, confirming the original disease classifications. Participants of this webinar will learn about the untargeted metabolomics workflow using the new X500R QTOF system. They will also gain a better understanding of how the X500R QTOF system allows the distinction between healthy and diseased cells. The team at SCIEX has arranged for Dr. Tim Garrett, an associate professor at the University of Florida, to be the speaker for this event. Garrett earned his doctorate in analytical chemistry from the University of Florida. He currently serves as an associate professor and director of high-throughput metabolomics for the Southeast Center for Integrated Metabolomics. Garrett's research is focused on the application and development of mass spectrometry techniques and instruments for clinical research and translation to clinical diagnostics. He has a specific interest in developing approaches to small molecule quantitation or characterization using mass spectrometry. LabRoots will host the webinar October, 24, 2017, beginning at 7:00 a.m. PDT, 10 a.m. EDT. To learn more about this event, discover the continuing education credits offered, or to simply register for free, click here. About SCIEX SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com. About LabRoots LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Loading SCIEX collaborators
Loading SCIEX collaborators